FOR PAYORS, LBMs, & EMPLOYERS:
Do you want to reduce ineffective yet costly precision medicine interventions that are initiated due to genetic/genomic test error? We have a prior authorization support service to help.
Many labs fail to follow professional standards of health care when assigning clinical significance to patients' genetic/genomic variation through a process called "variant classification". As a consequence, depending upon the lab, between ~ 5 - 50% of positive genetic/genomic test reports are false positives. Thus, "the most significant contributor to false positive test results is imperfect variant classification."
-The Science and Art of Clinical Genetic Variant Classification and Its Impact on Test Accuracy. Annual Review of Genomics and Human Genetics. 2021 Aug 31;22:285-307.
ELEVATEGENETICS CLARITY TM is a precision medicine prior authorization support service that uses the plan member's genetic or genomic test report to flag potential false-positive laboratory test results that may have arisen due to the lab's failure to follow generally accepted professional standards for variant classification.
ELEVATEGENETICS CLARITY TM can protect plan members from inappropriate and unnecessary precision drugs or surgeries that are unlikely to work.
ELEVATEGENETICS CLARITYTM
Sample Report
Most clinical labs that are alerted to a mistake in one of their variant classifications will correct the error and issue an amended report. This often results in a "positive" genetic/genomic test report being amended by the original clinical laboratory to either "uncertain" or "negative". Often this amendment removes the patient from precision therapy consideration.
ELEVATEGENETICS® assessments are informed by professionaly recognized standards and benchmarks from these organizations, when appropriate: